Current and future treatment strategies for iron overload cardiomyopathy
© 2015 Elsevier B.V. All rights reserved. Iron overload cardiomyopathy is the major cause of death in transfusion-dependent thalassemia (TDT) patients. Growing evidence demonstrates that combined iron chelators, or the combination of an iron chelator with antioxidant(s) are effective in diminishing...
Saved in:
Main Authors: | Suwakon Wongjaikam, Sirinart Kumfu, Siriporn C. Chattipakorn, Suthat Fucharoen, Nipon Chattipakorn |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84940040361&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/54836 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Current and future treatment strategies for iron overload cardiomyopathy
by: Suwakon Wongjaikam, et al.
Published: (2018) -
Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice
by: Juthamas Khamseekaew, et al.
Published: (2018) -
T-type and L-type calcium channel blockers for the treatment of cardiac iron overload: An update
by: Sirinart Kumfu, et al.
Published: (2018) -
Effects of iron overload condition on liver toxicity and hepcidin/ferroportin expression in thalassemic mice
by: Sirinart Kumfu, et al.
Published: (2018) -
Combined iron chelator and T-type calcium channel blocker exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice
by: Sirinart Kumfu, et al.
Published: (2018)